News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
147,080 Results
Type
Article (4797)
Company Profile (97)
Press Release (142181)
Multimedia
Podcasts (4)
Webinars (7)
Section
Business (44705)
Career Advice (210)
Deals (6833)
Drug Delivery (15)
Drug Development (18419)
Employer Resources (19)
FDA (1718)
Job Trends (2903)
News (70847)
Policy (4093)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (308)
Accelerated approval (8)
Adcomms (1)
Allergies (34)
Alliances (12725)
ALS (55)
Alzheimer's disease (442)
Antibody-drug conjugate (ADC) (104)
Approvals (1809)
Artificial intelligence (108)
Autoimmune disease (66)
Automation (13)
Bankruptcy (38)
Best Places to Work (2336)
BIOSECURE Act (14)
Biosimilars (32)
Biotechnology (86)
Bladder cancer (46)
Brain cancer (13)
Breast cancer (198)
Cancer (1401)
Cardiovascular disease (52)
Career advice (202)
Career pathing (5)
CAR-T (129)
Cell therapy (331)
Cervical cancer (9)
Clinical research (16321)
Collaboration (601)
Compensation (294)
Complete response letters (5)
COVID-19 (471)
CRISPR (26)
C-suite (383)
Cystic fibrosis (46)
Data (2033)
Depression (22)
Diabetes (107)
Diagnostics (861)
Digital health (1)
Diversity, equity & inclusion (8)
Drug discovery (97)
Drug pricing (9)
Drug shortages (2)
Duchenne muscular dystrophy (51)
Earnings (14132)
Editorial (5)
Employer resources (19)
Events (27343)
Executive appointments (392)
FDA (2449)
Fibrodysplasia Ossificans Progressiva (3)
Frontotemporal dementia (14)
Funding (491)
Gene editing (55)
Generative AI (12)
Gene therapy (176)
GLP-1 (171)
Government (386)
Guidances (76)
Healthcare (1799)
HIV (9)
Huntington's disease (13)
IgA nephropathy (41)
Immunology and inflammation (72)
Immuno-oncology (14)
Indications (29)
Infectious disease (530)
Inflammatory bowel disease (76)
Inflation Reduction Act (1)
Influenza (37)
Intellectual property (84)
Interviews (19)
IPO (3150)
IRA (4)
Job creations (698)
Job search strategy (185)
JPM (3)
Kidney cancer (3)
Labor market (16)
Layoffs (42)
Leadership (2)
Legal (768)
Liver cancer (17)
Longevity (2)
Lung cancer (132)
Lymphoma (146)
Machine learning (15)
Management (5)
Manufacturing (259)
MASH (19)
Medical device (584)
Medtech (587)
Mergers & acquisitions (4041)
Metabolic disorders (231)
Multiple sclerosis (57)
NASH (1)
Neurodegenerative disease (83)
Neuropsychiatric disorders (16)
Neuroscience (784)
Neurotech (1)
NextGen: Class of 2026 (894)
Non-profit (279)
Now hiring (7)
Obesity (98)
Opinion (41)
Ovarian cancer (69)
Pain (52)
Pancreatic cancer (75)
Parkinson's disease (105)
Partnered (6)
Patents (139)
Patient recruitment (167)
Peanut (17)
People (17696)
Pharmaceutical (10)
Phase 1 (6359)
Phase 2 (7771)
Phase 3 (4113)
Pipeline (1560)
Policy (33)
Postmarket research (249)
Preclinical (2723)
Press Release (51)
Prostate cancer (50)
Psychedelics (5)
Radiopharmaceuticals (55)
Rare diseases (176)
Real estate (1561)
Recruiting (10)
Regulatory (3781)
Reports (15)
Research institute (329)
Resumes & cover letters (20)
Rett syndrome (9)
RNA editing (4)
RSV (13)
Schizophrenia (17)
Series A (94)
Series B (75)
Service/supplier (3)
Sickle cell disease (24)
Special edition (3)
Spinal muscular atrophy (40)
Sponsored (5)
Startups (1053)
State (1)
Stomach cancer (2)
Supply chain (23)
Tariffs (9)
The Weekly (4)
Vaccines (131)
Venture capital (19)
Weight loss (41)
Women's health (9)
Worklife (2)
Date
Today (14)
Last 7 days (143)
Last 30 days (550)
Last 365 days (8759)
2026 (978)
2025 (8829)
2024 (9485)
2023 (10278)
2022 (13453)
2021 (13957)
2020 (10817)
2019 (7295)
2018 (5660)
2017 (6599)
2016 (6019)
2015 (7050)
2014 (5393)
2013 (4438)
2012 (4849)
2011 (5270)
2010 (4845)
Location
Africa (146)
Alabama (52)
Alaska (1)
Arizona (36)
Arkansas (2)
Asia (9414)
Australia (2205)
California (3703)
Canada (943)
China (283)
Colorado (73)
Connecticut (128)
Delaware (62)
Europe (23643)
Florida (389)
Georgia (56)
Hawaii (2)
Idaho (12)
Illinois (193)
India (18)
Indiana (199)
Iowa (3)
Japan (119)
Kansas (15)
Kentucky (3)
Louisiana (3)
Maine (2)
Maryland (383)
Massachusetts (2811)
Michigan (105)
Minnesota (158)
Mississippi (1)
Missouri (11)
Montana (11)
Nebraska (2)
Nevada (23)
New Hampshire (7)
New Jersey (708)
New Mexico (6)
New York (816)
North Carolina (453)
North Dakota (5)
Northern California (1837)
Ohio (68)
Oklahoma (7)
Oregon (7)
Pennsylvania (709)
Puerto Rico (9)
Rhode Island (6)
South America (217)
South Carolina (4)
Southern California (1448)
Tennessee (23)
Texas (504)
United States (11804)
Utah (41)
Virginia (27)
Washington D.C. (9)
Washington State (509)
West Virginia (1)
Wisconsin (22)
147,080 Results for "immatics biotechnologies gmbh".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Immatics Announces $125 Million Underwritten Offering
December 5, 2025
·
3 min read
Press Releases
Immatics Appoints Amie Krause as Chief People Officer
October 27, 2025
·
5 min read
Press Releases
Immatics Announces Third Quarter 2025 Financial Results and Business Update
November 18, 2025
·
21 min read
Press Releases
Immatics Appoints Venkat Ramanan as Chief Financial Officer
October 1, 2025
·
5 min read
Press Releases
Immatics Announces Second Quarter 2025 Financial Results and Business Update
August 13, 2025
·
18 min read
Press Releases
Immatics Highlights Compelling Anti-Tumor Activity of Anzu-cel PRAME Cell Therapy in Metastatic Uveal Melanoma at the ESMO 2025 Presidential Symposium
October 21, 2025
·
9 min read
Press Releases
Immatics Presents IMA203CD8 PRAME Cell Therapy Data from Ongoing Dose Escalation and Shows Promising Initial Anti-tumor Activity in PRAME-Positive Tumors at ESMO-IO 2025 Congress
December 11, 2025
·
10 min read
Press Releases
Croma-Pharma GmbH Enters Strategic Distribution Partnership with Renellence in Canada
October 10, 2025
·
2 min read
Press Releases
IBA integrates Artificial Intelligence Quality Assurance into dosimetry solutions through the acquisition of PhantomX GmbH
November 3, 2025
·
2 min read
Press Releases
Immatics Achieves Clinical Proof-of-Concept of its Next-Generation TCR Bispecific (TCER®) Pipeline with Data on IMA402 (PRAME) and IMA401 (MAGEA4/8) and Announces Next Development Steps
November 13, 2025
·
16 min read
1 of 14,708
Next
